Biperiden Trial for Epilepsy Prevention

PHASE3RecruitingINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

December 20, 2026

Study Completion Date

December 20, 2026

Conditions
Brain Injury Traumatic ModerateBrain Injury Traumatic SeverePost Traumatic Epilepsy
Interventions
DRUG

Biperiden

5mg of biperiden diluted in 100 ml of 0.9% saline - every 6 hours for 10 consecutive days - IV

OTHER

Placebo

1ml sterile vehicle (sodium lactate, lactic acid, sodium hydroxide and water for injections) diluted in 100 ml 0.9% saline - every 6 hours for 10 consecutive days - IV

Trial Locations (10)

Unknown

NOT_YET_RECRUITING

Instituto Doutor José Frota, Fortaleza

RECRUITING

Santa Casa de Misericórdia de Sobral, Sobral

NOT_YET_RECRUITING

Hospital Estadual Urgencia e Emergencia -HEUE, Vitória

RECRUITING

Hospital São Rafael, Salvador

RECRUITING

Associação Beneficente Santa Casa de Campo Grande, Campo Grande

ACTIVE_NOT_RECRUITING

Hospital São Vicente de Paulo, Passo Fundo

RECRUITING

Hospital das Clínicas da Faculdade de Medicina da Universidade de Ribeirão Preto, Ribeirão Preto

RECRUITING

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

NOT_YET_RECRUITING

Hospital São Paulo, Universidade Federal de São Paulo, São Paulo

01308-000

RECRUITING

Hospital Sirio-Libanes, São Paulo

All Listed Sponsors
collaborator

PROADI-SUS

UNKNOWN

collaborator

Ministry of Health, Brazil

OTHER_GOV

collaborator

University of Sao Paulo

OTHER

collaborator

Santa Casa de Campo Grande

OTHER

collaborator

Hospital Sao Rafael

OTHER

collaborator

Santa Casa de Misericórdia de Sobral

UNKNOWN

collaborator

Hospital de Clinicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

UNKNOWN

collaborator

Hospital São Paulo, Universidade Federal de São Paulo

UNKNOWN

collaborator

Instituto Doutor José Frota

UNKNOWN

collaborator

Hospital São Vicente de Paulo

UNKNOWN

lead

Hospital Sirio-Libanes

OTHER